Voltage-gated sodium channel blockers can augment the efficacy of chemotherapeutics by their inhibitory effect on epithelial–mesenchymal transition

• Published in: Medical hypotheses 2015-01, Vol.84 (1), p.11-13
• Main Authors: Eren, Orhan Onder, Ozturk, Mehmet Akif, Sonmez, Ozlem Uysal, Oyan, Basak
• Format: Article
• Language: English
• Subjects: Epithelial-Mesenchymal Transition - drug effects; Humans; Internal Medicine; Models, Biological; Neoplasm Metastasis - prevention & control; Neovascularization, Pathologic - prevention & control; Voltage-Gated Sodium Channel Blockers - metabolism; Voltage-Gated Sodium Channel Blockers - pharmacology
• ISSN: 0306-9877; 1532-2777
• DOI: 10.1016/j.mehy.2014.11.006

Abstract Epithelial–mesenchymal transition (EMT) is a process during which cancer cells become more invasive and chemo resistant. EMT may also be associated with tumor dormancy which prevents the cure of cancer with adjuvant treatment. Chemo resistance and dormancy may also decrease response to cytotoxic agents during treatment of metastatic disease. Voltage gated sodium channels (VGSCs) are overexpressed in many cancer types, particularly in those with more aggressive and metastatic potential. VGSCs are thought to be associated with increased invasive and migratory capacity of cancer cells. Inhibition of VGSCs may inhibit EMT and angiogenesis through interaction with intracellular calcium activity and endothelial cells respectively. Blockage of these channels combined with other anticancer therapies may be effective in both adjuvant and palliative setting. Colonization at secondary site may be decelerated by VGSCs inhibition through impeding angiogenesis. This may lead to a temporary palliation of symptoms related to tumor burden in patients with metastatic disease.